Central Nervous System (CNS) therapies have significantly progressed in the last decade, propelled by emerging treatment modalities including gene therapies. Neurological indications remain amongst ...

Blue Oak has been operating largely under the radar since it was set up in 2016, but has quietly started building alliances as it prepares to advance new drug classes for central nervous system ...

The two companies will work together on the development of a “next-generation” of psychiatric medicines, although – for now – the drugs themselves and the target indications are being kept ...

The fundamentals of Novo and Lilly do look robust, but it is always wise to avoid putting all of your eggs in one basket.

Vice President, Neuroscience, Genentech, South San Francisco, California, USA. Morgan Sheng started at Genentech in September 2008, having previously spent 14 years as a faculty member in the ...

Readers hoping to buy Cohen & Steers, Inc. ( NYSE:CNS ) for its dividend will need to make their move shortly, as the... Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under ...

After hours: December 10 at 4:02:46 PM EST ...

CNS specialist Noema Pharma AG has added a further $44 million to its series B, bringing the total for the round to $147 million. The new financing bolsters the balance sheet as the Basel, Switzerland ...

Several were found in possession of multiple over-the-counter drugs ... on the central nervous system to relieve coughing. It went on the market in August 2021. It comes in a small, easy-to ...

Looking for a healthier coffee routine? Learn how to brew with benefits, from antioxidants to sustainable options and simple, ...

How much coffee is too much? This guide explores what to know about moderating your caffeine consumption for good health. The ...